Details
| Stereochemistry | RACEMIC |
| Molecular Formula | C13H16O3 |
| Molecular Weight | 220.2643 |
| Optical Activity | ( + / - ) |
| Defined Stereocenters | 2 / 2 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
OC(=O)[C@H]1CCCC[C@]1(O)C2=CC=CC=C2
InChI
InChIKey=VCZPUGSOJXZKIP-YPMHNXCESA-N
InChI=1S/C13H16O3/c14-12(15)11-8-4-5-9-13(11,16)10-6-2-1-3-7-10/h1-3,6-7,11,16H,4-5,8-9H2,(H,14,15)/t11-,13+/m1/s1
| Molecular Formula | C13H16O3 |
| Molecular Weight | 220.2643 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 2 / 2 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Cicloxilic acid is a choleretic agent. Cicloxilic acid feeding lowered bile saturation (though bile tended to remain more saturated than normal) without affecting total bile acid pool size. The efficacy of cicloxilic acid in lowering biliary cholesterol saturation was not due to changes of dietary cholesterol absorption or of hepatic cholesterol synthesis. Hepatic cholesterogenesis and dietary cholesterol absorption are unaffected by cicloxilic acid feeding. Since cicloxilic acid is safe, cheap and lowers bile cholesterol saturation, this compound might have a place in gallstone disease either in association with the litholytic bile acids or in prevention of stone formation in high-risk populations (diabetics, obese, hyperlipidemic, etc.).
Approval Year
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/6360773
240 mg/day for 1 month
Route of Administration:
Oral
| Substance Class |
Chemical
Created
by
admin
on
Edited
Wed Apr 02 08:42:37 GMT 2025
by
admin
on
Wed Apr 02 08:42:37 GMT 2025
|
| Record UNII |
18WJ167MZN
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C66913
Created by
admin on Wed Apr 02 08:42:37 GMT 2025 , Edited by admin on Wed Apr 02 08:42:37 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
C018873
Created by
admin on Wed Apr 02 08:42:37 GMT 2025 , Edited by admin on Wed Apr 02 08:42:37 GMT 2025
|
PRIMARY | |||
|
100000081287
Created by
admin on Wed Apr 02 08:42:37 GMT 2025 , Edited by admin on Wed Apr 02 08:42:37 GMT 2025
|
PRIMARY | |||
|
134906
Created by
admin on Wed Apr 02 08:42:37 GMT 2025 , Edited by admin on Wed Apr 02 08:42:37 GMT 2025
|
PRIMARY | |||
|
21095
Created by
admin on Wed Apr 02 08:42:37 GMT 2025 , Edited by admin on Wed Apr 02 08:42:37 GMT 2025
|
PRIMARY | RxNorm | ||
|
C77836
Created by
admin on Wed Apr 02 08:42:37 GMT 2025 , Edited by admin on Wed Apr 02 08:42:37 GMT 2025
|
PRIMARY | |||
|
18WJ167MZN
Created by
admin on Wed Apr 02 08:42:37 GMT 2025 , Edited by admin on Wed Apr 02 08:42:37 GMT 2025
|
PRIMARY | |||
|
SUB06253MIG
Created by
admin on Wed Apr 02 08:42:37 GMT 2025 , Edited by admin on Wed Apr 02 08:42:37 GMT 2025
|
PRIMARY | |||
|
DTXSID701024145
Created by
admin on Wed Apr 02 08:42:37 GMT 2025 , Edited by admin on Wed Apr 02 08:42:37 GMT 2025
|
PRIMARY | |||
|
CHEMBL2104042
Created by
admin on Wed Apr 02 08:42:37 GMT 2025 , Edited by admin on Wed Apr 02 08:42:37 GMT 2025
|
PRIMARY | |||
|
260-966-6
Created by
admin on Wed Apr 02 08:42:37 GMT 2025 , Edited by admin on Wed Apr 02 08:42:37 GMT 2025
|
PRIMARY | |||
|
68776
Created by
admin on Wed Apr 02 08:42:37 GMT 2025 , Edited by admin on Wed Apr 02 08:42:37 GMT 2025
|
PRIMARY | |||
|
638
Created by
admin on Wed Apr 02 08:42:37 GMT 2025 , Edited by admin on Wed Apr 02 08:42:37 GMT 2025
|
PRIMARY | |||
|
3282
Created by
admin on Wed Apr 02 08:42:37 GMT 2025 , Edited by admin on Wed Apr 02 08:42:37 GMT 2025
|
PRIMARY | |||
|
57808-63-6
Created by
admin on Wed Apr 02 08:42:37 GMT 2025 , Edited by admin on Wed Apr 02 08:42:37 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |